Cargando…

Penicillin plus Ceftriaxone versus Ampicillin plus Ceftriaxone Synergistic Potential against Clinical Enterococcus faecalis Blood Isolates

Penicillin plus ceftriaxone is a promising alternative to ampicillin plus ceftriaxone for the treatment of Enterococcus faecalis infective endocarditis. Limited data is available supporting the utilization of penicillin plus ceftriaxone. A total of 20 E. faecalis isolates; one wild-type strain (JH2-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cusumano, Jaclyn A., Khan, Ruhma, Shah, Zeel, Philogene, Cassie, Harrichand, Amrita, Huang, Vanthida
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430804/ https://www.ncbi.nlm.nih.gov/pubmed/35703558 http://dx.doi.org/10.1128/spectrum.00621-22

Ejemplares similares

1522. Penicillin plus ceftaroline against Enterococcus faecalis blood isolates lacking ampicillin plus ceftriaxone activity
por: Nwoye, Angella, et al.
Publicado: (2022)

681. Penicillin Plus Ceftriaxone Against Enterococcus faecalis In Vitro Time-Kill Studies
por: Khan, Ruhmazia, et al.
Publicado: (2021)

Ampicillin Plus Ceftriaxone Combined Therapy for Enterococcus faecalis Infective Endocarditis in OPAT
por: Herrera-Hidalgo, Laura, et al.
Publicado: (2021)

Ampicillin Plus Ceftriaxone Regimen against Enterococcus faecalis Endocarditis: A Literature Review
por: Marino, Andrea, et al.
Publicado: (2021)

1559. Ertapenem Plus Ceftriaxone or Ceftaroline Dual Β-Lactam Combination for Enterococcus faecalis
por: Cusumano, Jaclyn A, et al.
Publicado: (2019)

Time to abandon ampicillin plus gentamicin in favour of ampicillin plus ceftriaxone in Enterococcus faecalis infective endocarditis? A meta-analysis of comparative trials
por: Mirna, Moritz, et al.
Publicado: (2021)

In Vitro Synergism of Penicillin and Ceftriaxone against Enterococcus faecalis
por: Thieme, Lara, et al.
Publicado: (2021)

Ampicillin plus ceftriaxone therapy against Enterococcus faecalis endocarditis: A case report, guidelines considerations, and literature review
por: Marino, Andrea, et al.
Publicado: (2022)

Four weeks versus six weeks of ampicillin plus ceftriaxone in Enterococcus faecalis native valve endocarditis: A prospective cohort study
por: Ramos-Martínez, Antonio, et al.
Publicado: (2020)

Ampicillin-Ceftriaxone vs Ampicillin-Gentamicin for Definitive Therapy of Enterococcus faecalis Infective Endocarditis: A Propensity Score–Matched, Retrospective Cohort Analysis
por: Shah, Niyati H, et al.
Publicado: (2021)

In vitro Antimicrobial Activity of Ampicillin-Ceftriaxone and Ampicillin-Ertapenem Combinations Against Clinical Isolates of Enterococcus faecalis with High Levels of Aminoglycoside Resistance
por: Pasticci, Maria Bruna, et al.
Publicado: (2008)

700. Ampicillin-Ceftriaxone Versus Ampicillin-Gentamicin for Definitive Therapy of Enterococcus faecalis Infective Endocarditis: A Propensity Score-Matched,Retrospective Cohort Analysis
por: Shah, Niyati H, et al.
Publicado: (2020)

Stability of Ampicillin plus Ceftriaxone Combined in Elastomeric Infusion Devices for Outpatient Parenteral Antimicrobial Therapy
por: Fernández-Rubio, Beatriz, et al.
Publicado: (2023)

370. The comparison of adverse events in combination with double beta-lactam antimicrobials: Ampicillin plus Ceftriaxone and Ampicillin/Cloxacillin with bloodstream infections
por: Ishikawa, Kazuhiro, et al.
Publicado: (2023)

A new pharmacodynamic approach to study antibiotic combinations against enterococci in vivo: Application to ampicillin plus ceftriaxone
por: Jimenez-Toro, Ivone, et al.
Publicado: (2020)

184. Implications of Enterococcus faecalis penicillin susceptibility in patients with bacteremia
por: Hedvat, Jason, et al.
Publicado: (2023)

In vitro study of synergy of ampicillin with ceftriaxone against Listeria monocytogenes
por: Lepe, José Antonio, et al.
Publicado: (2019)

Amoxicillin and Ceftriaxone as Treatment Alternatives to Penicillin for Maternal Syphilis
por: Katanami, Yuichi, et al.
Publicado: (2017)

2197. Ceftriaxone Monotherapy vs. Ceftriaxone Plus Azithromycin for the Treatment of Community-Acquired Pneumonia in Hospitalized, Non-ICU Patients
por: Murter, Forrest, et al.
Publicado: (2019)

Antiamoebic Properties of Ceftriaxone and Zinc-Oxide–Cyclodextrin-Conjugated Ceftriaxone
por: Makhlouf, Zinb, et al.
Publicado: (2022)

Clinical characteristics of ceftriaxone plus metronidazole in complicated intra-abdominal infection
por: Bae, Jung Min
Publicado: (2015)

Comparison of ceftriaxone plus macrolide and ampicillin/sulbactam plus macrolide in treatment for patients with community-acquired pneumonia without risk factors for aspiration: an open-label, quasi-randomized, controlled trial
por: Hamao, Nobuyoshi, et al.
Publicado: (2020)

Response of HIV-infected patients with syphilis to therapy with penicillin or intravenous ceftriaxone
por: Spornraft-Ragaller, P, et al.
Publicado: (2011)

Comparative activities of ampicillin and teicoplanin against Enterococcus faecalis isolates
por: Zacharopoulos, Georgios V., et al.
Publicado: (2023)

Effect of sub-inhibitory concentrations of antibiotics on biofilm formation and expression of virulence genes in penicillin-resistant, ampicillin-susceptible Enterococcus faecalis
por: Caixeta Magalhães Tibúrcio, Aline Andréia, et al.
Publicado: (2022)

An alternative penicillin-binding protein involved in Salmonella relapses following ceftriaxone therapy
por: Castanheira, Sónia, et al.
Publicado: (2020)

Evolution of Ceftriaxone Resistance of Penicillin-Binding Proteins 2 Revealed by Molecular Modeling
por: Krivitskaya, Alexandra V., et al.
Publicado: (2022)

Penicillin-Susceptible Streptococcus pneumoniae Meningitis in Adults: Does the Ceftriaxone Dosing Matter?
por: Raemy, Samuel, et al.
Publicado: (2023)

The efficacy of ampicillin compared with ceftriaxone on preventing cesarean surgical site infections: an observational prospective cohort study
por: Assawapalanggool, Srisuda, et al.
Publicado: (2018)

Clinical Outcomes of Ceftriaxone vs Penicillin G for Complicated Viridans Group Streptococci Bacteremia
por: Wo, Stephanie, et al.
Publicado: (2020)

Ceftriaxone and Melittin Synergistically Promote Wound Healing in Diabetic Rats
por: Alhakamy, Nabil A., et al.
Publicado: (2021)

1826. Comparative Use of Vancomycin versus Ampicillin for Blood Stream Infections Caused by Ampicillin-susceptible Enterococcus faecalis
por: Phan, Michaele, et al.
Publicado: (2022)

Ceftriaxone-induced hemolysis
por: Guleria, Vivek S., et al.
Publicado: (2013)

Ceftriaxone‐associated pseudolithiasis
por: Kurihara, Masaru, et al.
Publicado: (2021)

270. Clinical Outcomes of Ceftriaxone versus Penicillin G for Complicated Viridans Group Streptococci Bacteremia
por: Wo, Stephanie, et al.
Publicado: (2020)

Ceftriaxone‐induced neutropenia successfully overcome by a switch to penicillin G in Cardiobacterium hominis endocarditis
por: Nau, Roland, et al.
Publicado: (2023)

Comparison between Ceftriaxone and Sulbactam-Ampicillin as Initial Treatment of Community-Acquired Pneumonia: A Systematic Review and Meta-Analysis
por: Kato, Hideo, et al.
Publicado: (2022)

Ceftriaxone-Associated Severe Acute Hepatitis
por: Asif, Muhammad, et al.
Publicado: (2023)

Cholestatic hepatitis with intravenous ceftriaxone
por: Kaur, Inderpal, et al.
Publicado: (2011)

Ceftriaxone–Associated Nephrolithiasis in Children
por: Fesharakinia, Azita, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_psbc4ecudp2p7fto6pudnnv2tl